Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration | MicrobiomeTrials← Back to trialsNCT07367282
Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-06-29Est. Completion: 2028-04-30
Enrollment target: 64 participants Locations- Seoul National University Bundang Hospital, Seongnam, South Korea
- Asan Medical Center, Seoul, South Korea
- Kyung Hee University Medical Center, Seoul, South Korea
- Samsung Medical Center, Seoul, South Korea
- Seoul St. Mary's Hospital, Seoul, South Korea
Other microbiome trials you might be interested in
Age-Related Macular Degeneration
The main objective of the study is evaluation of the safety and tolerability of OpRegen - Human embryonic stem cell-deri…
San Francisco, United StatesEst. completion Dec 31, 2021
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Primary objective:
• To evaluate the change in aqueous humor vascular endothelial growth factor A (VEGF-A) levels after…
Multiple LocationsEst. completion Aug 15, 2026